Table 3.

Treatment outcomes of patients with anterior uveitis and posterior/panuveitis treated with methotrexate.

	Anterior uveitis	Posterior/Panuveitis
Number of patients, eyes	15 patients, 25 eyes	20 patients, 40 eyes
Median age of onset	39	43
Median follow-up period (months)	44	44
Duration of uveitis before starting methorexate (months)	63.6	12.6*
Percentage of eyes with peripheral anterior synechia (%)	68	52.5
Percentage of eyes with steroid induced intraocular pressure elevation (%)	40	45
Mean dose of corticosteroids (mg/day)	12.6	11.6
Baseline
12 months	1.1	0.1
Percentage of eyes with inactive uveitis at 12 months (%)	59.1	60.1

^*Significant difference observed (Mann-Whitney U test, p < 0.05).